FindTrial
Sign In

Benzodiazepines as first-line treatment for status epilepticus in adults: A systematic review and meta-analysis

Benzodiazepines as first-line treatment for status epilepticus in adults: A systematic review and meta-analysis - Benzodiazepines as first-line treatment for status epilepticus in adults: A systematic review and meta-analysis

Status
Active, not recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000058473
Enrollment
Unknown
Registered
2025-07-15
Start date
2024-06-18
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

status epilepticus

Interventions

None listed

Sponsors

Guideline committee of Japan Resuscitation Council (Neuroresuscitation)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Randomized controlled trials (RCTs) 2) Studies involving patients with status epilepticus 3) Studies evaluating acute-phase treatment using lorazepam, midazolam, or diazepam, from initial emergency care through intensive care unit (ICU) management 4) English or Japanese

Exclusion criteria

Exclusion criteria: Conference abstract

Design outcomes

Primary

MeasureTime frame
mortality, clinical seizure cessation, poor neurological outcome, endotracheal intubation, seizure recurrence.—

Countries

Japan

Contacts

Public ContactEisei Hoshiyama

Dokkyo Medical University Department of Neurology and Emergency and Critical Care Center

eisei@dokkyomed.ac.jp0282861111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026